CLIA lab

CLIA 14D2184059: Abbvie Clinical Pharmacology Research Unit (Acpru)

Grayslake, IL. Certificate and address details from the CMS Provider of Services file for clinical laboratories.

CLIA number 14D2184059 belongs to Abbvie Clinical Pharmacology Research Unit (Acpru) in Grayslake, IL.

Certificate of Waiver, effective May 14, 2026, expires May 13, 2028.

Active in the CMS Provider of Services file posted October 16, 2026.

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Run it in Rivvi

Map your lab's test names to LOINC codes

Open in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Certificate

Certificate type
Certificate of Waiver
Certificate effective
May 14, 2026
Certificate expiration
May 13, 2028
Status in the CMS file
Active (termination code 00)
Original participation date
May 14, 2020
Facility type
Other
Ownership (control type)
Proprietary
Lab classification
CLIA laboratory

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Lab and contact

CLIA number
14D2184059
Lab name
Abbvie Clinical Pharmacology Research Unit (Acpru)
Address
480 S U S 45, Grayslake, IL 60030
Phone
(847) 935-4438
Fax
(847) 935-4002

Annual test volume the lab reported

Waived tests
2,200

Volumes are what the lab reported to CMS on its CMS-116 application, as carried in the file.

Other labs in Grayslake, IL

Related

Questions

What is the CLIA number for Abbvie Clinical Pharmacology Research Unit (Acpru) in Grayslake?

14D2184059, per the CMS Provider of Services file posted October 16, 2026.

What CLIA certificate does Abbvie Clinical Pharmacology Research Unit (Acpru) hold?

A Certificate of Waiver, according to the CMS file.

When does CLIA 14D2184059 expire?

The CMS file lists May 13, 2028 as the certificate expiration date; the certificate took effect May 14, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.